Abstract
To the Editor: In March 2020, the National Comprehensive Cancer Network recommended delaying treatment during the COVID-19 pandemic for keratinocyte carcinoma (KC), except for tumors determined to pose a risk of “metastasis or debilitating progression within 3 months.”1 This study sought to evaluate the impact of the COVID-19 pandemic on cancer worry in patients undergoing Mohs micrographic surgery (MMS) for KCs.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
